US 6638543
Use of natural EGFR inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth factor receptor
expired A61KA61K2800/70A61K31/07
Quick answer
US patent 6638543 (Use of natural EGFR inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth factor receptor) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Oct 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Oct 28 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2800/70, A61K31/07, A61K31/202, A61K31/353